For example, the evaluated expression of TPD52L2 could accelerate the proliferation and invasiveness of glioma cells by regulating WNT signaling (Qiang et al., 2018), which provides a theoretical basis for the application of new medicine in tumor targeted therapy. This evidence concerns the gene TPD52L2 and neoplasm.